Aim: to study clinicomorphological efficacy of inhalation glucocorticosteroid budesonide (benacort, Pulmomed, Russia) in bronchial asthma.
Material And Methods: Twenty patients with bronchial asthma were treated with budesonide.
Results: A response to budesonide was manifest to the end of treatment week 1.